(2021)
Performance of three SARS-CoV-2 immunoassays, three rapid lateral flow tests, and a novel bead-based affinity surrogate test for the detection of SARS-CoV-2 antibodies in human serum.
J Clin Microbiol 59(8),
e0031921.
Oliver Kurzai
National Reference Center for Invasive Fungal Infections · Head Fungal Septomics · Head +49 3641 532-1347 oliver.kurzai@leibniz-hki.deCurriculum vitae
Main Research Areas
- Infection biology of human pathogenic fungi (especially Candida albicans)
- Infection biology of Neisseria meningitidis
Professional Career
| Since 2017 | Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena |
| 2009-2016 | Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena |
| 2008 | Habilitation in medical microbiology, University Würzburg |
| 2006 | Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer) |
| 2003 | Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg |
| 2001-2002 | Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg |
| 2002 | Dr. med., “summa cum laude” University Würzburg |
| 2001 | Staatsexamen (state examination) in human medicine, University Würzburg |
Awards · Appointments · Scientific Activities
| Since 2014 | Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk) |
| Since 2013 | Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena |
| Since 2012 | Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage) |
| Since 2012 | Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM) |
| Since 2011 | Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG |
| 2015-2016 | Speaker of the ZIK Septomics |
| 2011-2013 | Editor, Journal of Basic Microbiology |
| 2009 | Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG) |
| 2008 | Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
| 2003 | Science award from the Unterfränkische Gedenkjahrstiftung |
| 2003 | Dissertation award from the medical faculty of the University Würzburg |
| 2002 | Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
Publications
(2021)
Ex vivo immune profiling in patient blood enables quantification of innate immune effector functions.
Sci Rep 11(1),
12039.
(2021)
DAnIEL: A user-friendly web server for fungal ITS amplicon sequencing data.
Front Microbiol 12,
720513.
(2021)
Significant differences in host-pathogen interactions between murine and human whole blood.
Front Immunol 11,
565869.
(2021)
The zinc cluster transcription factor Czf1 regulates cell wall architecture and integrity in Candida albicans.
Mol Microbiol 116(2),
483-497.
(2021)
Results from the German fungal keratitis registry: Significant differences between cases with and without a history of contact lens use.
Cornea 40(11),
1453-1461.
(2021)
Comparison of two commercially available qPCR kits for the detection of Candida auris.
J Fungi (Basel) 7(2),
154.
(2021)
Floating fungus balls in a blood culture bottle.
Clin Microbiol Infect 27(12),
1790-1791.
(2021)
Transient mitochondria dysfunction confers fungal cross-resistance against phagocytic killing and fluconazole.
mBio 12(3),
e0112821.
(2021)
Diagnostic performance of (1→3)-β-D-glucan alone and in combination with Aspergillus PCR and galactomannan in serum of pediatric patients after allogeneic hematopoietic stem cell transplantation.
J Fungi (Basel) 7(3),
238.
